Dolby Laboratories (NYSE:DLB - Get Free Report) issued an update on its first quarter 2027 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.410-0.560 for the period, compared to the consensus earnings per share estimate of 1.060. The company issued revenue guidance of $285.0 million-$305.0 million, compared to the consensus revenue estimate of $358.3 million. Dolby Laboratories also updated its FY 2027 guidance to 4.270-4.420 EPS.
Analyst Ratings Changes
Several research firms have recently weighed in on DLB. Zacks Research upgraded Dolby Laboratories from a "strong sell" rating to a "hold" rating in a report on Friday. Wall Street Zen cut shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, September 9th. Finally, Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $85.00 to $80.00 and set a "buy" rating on the stock in a research report on Monday. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Dolby Laboratories currently has an average rating of "Moderate Buy" and an average target price of $85.00.
View Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Price Performance
NYSE:DLB traded down $2.56 during trading hours on Tuesday, reaching $58.60. 3,929,316 shares of the company were exchanged, compared to its average volume of 841,243. The business has a 50 day moving average of $60.97 and a 200 day moving average of $59.43. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $69.95. The company has a market capitalization of $5.49 billion, a P/E ratio of 24.94 and a beta of 0.79.
Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.05. The firm had revenue of $373.54 million during the quarter, compared to analysts' expectations of $372.76 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, equities research analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.
Dolby Laboratories declared that its Board of Directors has approved a share buyback program on Thursday, July 30th that authorizes the company to buy back $350 million in outstanding shares. This repurchase authorization authorizes the electronics maker to purchase up to 7% of its shares through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, CAO Ryan Nicholson sold 1,183 shares of the firm's stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares of the company's stock, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP John D. Couling sold 7,667 shares of the firm's stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 16,517 shares of company stock valued at $995,963. 37.93% of the stock is owned by insiders.
Recent Dolby Laboratories Headlines
Here are a few of the latest headlines about DLB:
- Positive Sentiment: Fiscal Q4 2026 EPS was $1.25, above the $1.20 consensus, while revenue of about $374 million slightly exceeded estimates and rose from $307 million a year earlier. Dolby Laboratories fiscal 2026 results
- Positive Sentiment: Zacks Research made small upward revisions to several 2027–2028 EPS estimates, including its FY2028 forecast to $3.40 from $3.38, though it maintained a Hold rating.
- Neutral Sentiment: Trading volume was substantially above its average, suggesting heightened investor activity around the earnings release; the reports do not establish what drove the market’s reaction.
About Dolby Laboratories
(
Get Free Report)
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.